Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (210)	2/24/1999 6:50:00 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 805

Ailing? Just Add Cells Now we can grow the cells from which all others derive, but ethical questions are involved smithsonianmag.si.edu The "research and clinical potential for human ES cells is enormous," he writes. They will be used for studies of normal and abnormal human embryo development (birth defects), to test new drugs and especially "as a renewable source of cells for tissue transplantation, cell replacement and gene therapies." Geron has been in a lazy trading range between 10 and 13, it is getting close to the bottom of that range now. CytoTherapeutics is in a range from 1.4 to 1.7 lately, and is also at the bottom of that range. Aastrom has also been a bit weak...and at 2 1/2 I'd buy it as well if I weren't putting all my stem cell chips on CTII. --Mike